[Wedge Resection of Pulmonary Nodules (≤2 cm): 
A Consensus Statement by Specialists of Thoracic Surgery (2023 Edition)].

Lung cancer is the highest cancer-related mortality rate in the world, and is one of the most common malignancies. The standard treatment for early-stage non-small cell lung cancer (NSCLC) is radical lobectomy, while recent studies have found that sub-lobectomy of pulmonary nodules (≤2 cm) is not inferior to lobectomy and even improve the prognosis of the patients. These important findings will effectively and positively promote the formation of consensus and principles of wedge resection of pulmonary nodules (≤2 cm) in the field of thoracic surgery. The purpose of this study is to present a national expert consensus on wedge resection of pulmonary nodules (≤2 cm) in the field of thoracic surgery. The experts from Editorial Committee of Consensus on Wedge Resection of Lung Nodules (≤2 cm) (2023 Edition) jointly participated in the revision work. According to the clinical progress about the wedge resection of pulmonary nodules (≤2 cm) at home and abroad during recent years, experts jointly wrote Wedge Resection of Pulmonary Nodules (≤2 cm): a Consensus Statement by Specialists of Thoracic Surgery (2023 Edition), in combination with the homogeneous treatment principles of wedge resection in the field of thoracic surgery in China. This consensus was summarized from the following aspects: (1) Indications of wedge resection of pulmonary nodules (≤2 cm); (2) Resection range of pulmonary nodules (≤2 cm) required for wedge resection; (3) Excisable pulmonary nodules (≤2 cm) for wedge resection. This consensus finally put forward 8 recommended opinions, and sorted out 5 opinions which were still controversial and needed more evidence. The integrated opinions were generated through the discussion held among the experts of thoracic surgery from all over the country, making wedge resection of pulmonary nodules (≤2 cm) more appropriate for China and more standardized and homogeneous for clinical practice. In the future, more relevant researches should be accumulated based on the characteristics of lung cancer and its diagnosis and treatment in China, optimizing the treatment of pulmonary nodules (≤2 cm).【中文题目：肺部结节（≤2 cm）楔形切除 胸外科全国专家共识（2023版）】 【中文摘要：肺癌是全球癌症相关死亡率最高的恶性肿瘤。早期非小细胞肺癌（non-small cell lung cancer, NSCLC）的治疗标准是根治性肺叶切除术，而近年来的各项研究发现肺部结节（≤2 cm）进行亚肺叶切除术不劣于标准肺叶切除术，甚至能改善患者预后。这些重要研究发现对于推进胸外科肺部结节（≤2 cm）的楔形切除形成行业共识与规范具有切实有效的积极意义。本共识的目的是提出肺部结节（≤2 cm）楔形切除在胸外科领域的全国专家共识。胸外科肺部结节（≤2 cm）楔形切除专家共识（2023版）编写委员会的各位专家共同参与了《肺部结节（≤2 cm）楔形切除胸外科全国专家共识（2023版）》的修订工作。专家们根据近年来国内外肺部结节（≤2 cm）楔形切除的临床研究进展，结合我国胸外科领域楔形切除的治疗规范，共同撰写了本次肺部结节（≤2 cm）楔形切除的全国专家共识。本共识从以下方面进行了整理：（1）肺部结节（≤2 cm）楔形切除的适应证；（2）肺部结节（≤2 cm）楔形切除的切除范围；（3）肺部结节（≤2 cm）适合楔形切除的方式。本次共识最终就8条推荐意见达成共识，并整理出5条尚存在争议、有待更多证据明确的意见，整合了全国胸外科各中心专家同道的意见，使得肺部结节（≤2 cm）的楔形切除更适应我国国情；使得肺部结节（≤2 cm）的楔形切除可以更加规范化、同质化地应用于临床。未来应基于我国肺癌诊治特点积累更多相关研究内容，以优化肺部结节（≤2 cm）的治疗决策。】 【中文关键词：肺部结节；楔形切除；共识】.